Follow
Cavit Boz
Cavit Boz
Karadeniz Tecnical University, Medical Faculty, Neurology
Verified email at ktu.edu.tr - Homepage
Title
Cited by
Cited by
Year
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9172018
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …
JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...
The Lancet Neurology 16 (12), 976-986, 2017
5552017
Relationship between major depression and heart rate variability.: Clinical consequences and implications for antidepressive treatment
MW Agelink, C Boz, H Ullrich, J Andrich
Psychiatry research 113 (1-2), 139-149, 2002
5472002
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3792016
Geographical variations in sex ratio trends over time in multiple sclerosis
M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ...
PloS one 7 (10), e48078, 2012
2592012
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis
VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ...
Annals of neurology 80 (1), 89-100, 2016
2082016
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ...
Multiple Sclerosis Journal 20 (6), 739-746, 2014
2032014
Defining reliable disability outcomes in multiple sclerosis
T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ...
Brain 138 (11), 3287-3298, 2015
2022015
Status epilepticus after stroke
SK Velioglu, M Özmenoğlu, C Boz, Z Alioglu
Stroke 32 (5), 1169-1172, 2001
1892001
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ...
Brain 136 (12), 3609-3617, 2013
1882013
Individual risk factors for carpal tunnel syndrome: an evaluation of body mass index, wrist index and hand anthropometric measurements
C Boz, M Ozmenoglu, V Altunayoglu, S Velioglu, Z Alioglu
Clinical neurology and neurosurgery 106 (4), 294-299, 2004
1872004
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ...
Annals of Neurology 77 (3), 425-435, 2015
1852015
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ...
PloS one 10 (6), e0122686, 2015
1812015
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ...
The Lancet Neurology 16 (4), 271-281, 2017
1672017
Fingolimod after natalizumab and the risk of short-term relapse
VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ...
Neurology 82 (14), 1204-1211, 2014
1552014
Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study
A Altintas, B Petek, N Isik, M Terzi, F Bolukbasi, M Tavsanli, S Saip, C Boz, ...
Multiple Sclerosis Journal 18 (10), 1448-1453, 2012
1522012
The impact of migraine on epilepsy: a prospective prognosis study
SK Velioglu, C Boz, M Özmenoglu
Cephalalgia 25 (7), 528-535, 2005
1172005
Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients
S Gazioglu, C Boz
Clinical neurophysiology 123 (9), 1872-1879, 2012
1142012
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ...
Brain 140 (9), 2426-2443, 2017
1052017
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta
C Boz, M Ozmenoglu, S Velioglu, K Kilinc, A Orem, Z Alioglu, ...
Clinical neurology and neurosurgery 108 (2), 124-128, 2006
1042006
The system can't perform the operation now. Try again later.
Articles 1–20